Audio By Carbonatix
Some $3bn (£2.4bn) will be invested over the next 10 years to end vaccine dependency across the continent, the Africa Development Bank (AfDB) has pledged.
The plan includes a new pharmaceutical centre for research, development and manufacturing based in Rwanda's capital, Kigali.
It has been widely lauded as key towards ending Africa’s dependence on outside donations, as recently witnessed during the Covid-19 pandemic
AfDB says it will also help patent and license African-made medicines, and support governments to navigate the intellectual property rights to global vaccines and medicines.
It follows a recent World Trade Organisation announcement of a partial waiver on coronavirus vaccine patents, allowing select developing countries to produce the jabs.
AfDB says Africa currently imports more than 70% of all its medicines, spending about $14bn every year.
Latest Stories
-
We must take critical look at SOEs and shed non-strategic ones – Dr Atuahene
1 hour -
Uber and AI-firm Wayve launch London’s first robotaxis
2 hours -
Trump $1 coin makes him first living president on US currency in a century
2 hours -
Sydney police investigate second possible mistaken identity killing in two days
2 hours -
Gauff’s flaw forgotten on winning US Open return
4 hours -
Birds stop play but Medvedev flies into third round
4 hours -
LA Clippers fined $30m by NBA over Leonard scandal
4 hours -
Uber to cut over 3,000 jobs in major global restructuring
4 hours -
Tiger Woods gets five-year driving ban after reckless driving plea
5 hours -
South African airline behind daring stadium stunt cancels next flyby
5 hours -
PURC urges ECG to address outages, metering delays
5 hours -
Police engage traders over alleged harassment, extortion on Aflao-Accra highway
5 hours -
Uber shuts operations in Nigeria and Uganda with immediate effect
5 hours -
Netherlands moves billions in gold to London in ‘crisis preparedness’ move
5 hours -
Legal vacation does not halt urgent court cases – Chief Justice
6 hours